OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 05, 2009
Also, recalls for two KV Pharmaceutical subsidiaries; Human Genome Sciences delivers anthrax drug to US Strategic National Stockpile; Akorn president and CEO leaves the company; more...
February 04, 2009
Cambrex CEO Steve Klosk looks to higher valued-added segments such as high-potency actives, controlled substances, and drug-delivery technologies to drive growth.
Several contract manufacturers announced capacity and service expansions at InformEx, the exhibition of custom and batch manufacturers, held in San Francisco, last week.
The financial crisis could lead to consolidation in the contract services industry.
February 02, 2009
Brief pharmaceutical news items for February 2009.
Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.
A recent reader poll focused on predictions for the industry's future.
The Romanian pharmacetuical market has grown significantly in recent years, but with stagnation on the horizon, a path forward is needed.
FDA's role should not be overlooked as it has been in years past.
February 01, 2009
The European dose CMO sector appears to be very vibrant, probably more so than the market in the US.